The Ramsay Health Care (ASX:RHC) share price is down 5% in 8 days. Could it be a buy?

Could Ramsay shares be a buy today?

| More on:
A worried doctor looks through a glass door.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Ramsay Health Care Limited (ASX: RHC) share price is having a pretty decent start to this Wednesday's trading. At the time of writing, Ramsay shares are up a healthy 0.31% to $68.38 a share.

However, zooming out, and the picture isn't quite so bright. Ramsay shares are now down around 5.1% since Friday 3 September. That's a pretty nasty drop for a 12-day span.

The company is faring… ok in 2021 so far, up close to 9% year to date. It's up a rather paltry 2.7% over the past 12 months. Compared to the S&P/ASX 200 Index (ASX: XJO), this is arguably quite poor, seeing as the ASX 200 is up close to 11% in 2021 so far, and almost 26% over the past year.

So what's been happening with Ramsay that might have sparked this recent bout of volatility?

Earnings and dividends…

Well, the short answer is… not much. Ramsay has announced no major news or developments since the announcement of its FY21 earnings report last month. Just to recap, the company reported a healthy lift in earnings by 29.1% to $1.13 billion, and a 58.1% jump in statutory profit to $449 million.

Of course, those numbers are coming off a low base, since FY20 was a pretty tough year for this healthcare company. But even so, investors seem to have given their approval, seeing as the Ramsay share price remains above it's pre-earnings pricing by around 0.7% as of today.

But perhaps the single biggest reason why Ramsay has had a rough couple of weeks is the company's dividend. Last month, in addition to the metrics above, Ramsay announced a final dividend for FY21 of $1.03 a share, bringing its full-year dividend to $1.515 per share.

Ramsay traded ex-dividend for this final payout on 6 September. This caused the usual share price dip, reflecting that new shareholders will not be eligible for the payout.

This dip (which is one of the best reasons to have a share drop in value) is the primary reason why Ramsay shares have gone backwards by around 5% since 3 September. Eligible shareholders will receive this dividend on 30 September.

So could Ramsay shares be a buy at these current levels?

Could the Ramsay Health Care share price a buy today?

Well, one fund manager who thinks so is Tribeca Investment Partners fund manager Jun Bei Liu. My Fool colleague Tony interviewed Ms Liu this week, and it turns out she is very bullish on Ramsay shares right now. Here's some of what she told the Motley Fool:

Ramsay, obviously private hospitals, and elective surgery at the moment is being suspended — it's having an earnings impact. However, remember, this is infrastructure-like, private hospital assets. It used to trade at such a big premium to the market, at a premium to the other healthcare businesses.

Now it trades just over 20 times [forward P/E ratio]. The rest of the healthcare sector trades at over 40. And this is a business, structurally, things are looking better, not looking at the pandemic.

At the current Ramsay Health Care share price, this company has a market capitalisation of $15.57 billion and a dividend yield of 2.22%.

Motley Fool contributor Sebastian Bowen owns shares of Ramsay Health Care Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Ramsay Health Care Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Three scientists wearing white coats and blue gloves dance together in a lab.
Share Market News

Is it too late to buy Pro Medicus shares?

Pro Medicus shares have risen 550% over 3 years. Have you missed the boat? Three experts weigh in.

Read more »

Researchers and doctors with futuristic 3d hologram overlay for body anatomy or dna in hospital clinic.
Healthcare Shares

These 5 ASX 200 healthcare shares gained the most weight in FY25

These stocks were in great health last financial year.

Read more »

Scientists working in the laboratory and examining results.
Healthcare Shares

Guess which ASX 300 healthcare stock is charging higher on product launch news

Investors have responded positively to this announcement.

Read more »

Three healthcare workers look and point at at medical image
Share Market News

Pro Medicus shares surge 10% to crack $300 as healthcare leads ASX 200 sectors

Pro Medicus shares just keep on going, rising 625% over the past three years.

Read more »

Shot of a mature scientists working on a laptop in a lab.
Healthcare Shares

Here are the latest growth forecasts for the CSL share price

Can this biotech giant deliver healthy returns?

Read more »

Three scientists wearing white coats and blue gloves dance together in a lab.
Healthcare Shares

UP 127% in a year, why is the Pro Medicus share price rocketing higher again today?

ASX investors are sending Pro Medicus shares flying higher on Thursday. But why?

Read more »

Broker looking at the share price on her laptop with green and red points in the background.
Healthcare Shares

These healthcare stocks could be set to double according to broker

Interested in gaining exposure to the healthcare sector? These options could be ones to watch. 

Read more »

Shot of two young scientists using a laptop in a laboratory.
Healthcare Shares

Up 250% in a year, how much higher can this ASX healthcare share climb?  

The future looks promising for this biotech firm after delivering a record-quarterly result.

Read more »